Why the study?
The study was conducted to investigate the relationship between serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase and the progression of coronary artery disease.
Do serum levels of LPL, HL, and EL predict the progression of coronary artery disease?
Do serum levels of LPL, HL, and EL predict the progression of coronary artery disease?
Elevated serum hepatic lipase (HL) is an independent risk factor for the progression of coronary artery disease.
Answers are grounded in this paper and cite their sources.
Elevated EL/HL levels were associated with CAD progression; leaves open their value as predictors or targets pending prospective studies.
PURPOSE: The purpose of this study was to investigate the relationship between serum levels of lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) and the progression of coronary artery disease (CAD). MATERIALS AND METHODS: According to the inclusion criteria, exclusion criteria, diagnostic criteria, angiography results, and the random matching scheme, the enrolled patients were divided into the following two groups: the progression-free group (n = 47) and the progression group (n = 15). The baseline characteristics and various biochemical parameters were obtained from the medical records and medical history. Serum LPL, HL, and EL levels were detected by ELISA. The correlation between serum LPL, HL, and EL levels and coronary lesions was statistically analyzed with SPSS software. RESULTS: Significant differences were observed in serum levels of HL and EL between the progression-free group and the progression group (HL, 75.5 ± 39.2 ng/mL vs. 125.1 ± 42.1 ng/mL, P < 0.05; EL, 139.2 ± 59.6 pg/mL vs. 175.1 ± 40.1 pg/mL, P < 0.05), while the difference in the LPL level was not significant (P > 0.05). Receiver operating characteristic curve (ROC) analysis showed that the area under the curve (AUC) values of LPL, HL, and EL were 0.506 (95% CI: 0.369-0.642, P = 0.9470), 0.792 (95% CI: 0.664-0.888, P < 0.0001), and 0.693 (95% CI: 0.553-0.811, P = 0.0095), respectively. Additionally, logistic regression analysis showed that the serum level of HL was an independent risk factor for coronary artery lesion progression. CONCLUSION: erum level of EL or LPL.
No takes yet. Share an insight, caveat, or question.
Han et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: